PFG
61
2
PVH
53
-2
DRI
45
-8
UA
38
-3
EQT
31
-5
MAS
63
-3
GRMN
43
-3
THC
62
-4
CVS
37
-2
BAX
47
3
M
34
-3
NVDA
63
-2
BRK.B
45
-4
NSC
67
8
GS
62
3
MKC
53
2
MU
42
-2
AAP
27
-8
USB
53
2
CAT
62
-2
PFG
61
2
PVH
53
-2
DRI
45
-8
UA
38
-3
EQT
31
-5
MAS
63
-3
GRMN
43
-3
THC
62
-4
CVS
37
-2
BAX
47
3
M
34
-3
NVDA
63
-2
BRK.B
45
-4
NSC
67
8
GS
62
3
MKC
53
2
MU
42
-2
AAP
27
-8
USB
53
2
CAT
62
-2
Financhill
Back

SpringWorks Therapeutics Quote, Financials, Valuation and Earnings

Gold Set to Skyrocket as Fed Slashes Rates

Click here for the details on this incredible opportunity.
Sell
29

SWTX
SpringWorks Therapeutics

Last Price:
28.57
Seasonality Move:
39.52%

7 Day Trial

ALL ACCESS PASS

$ 7

Don't put a penny in AI stocks until you read this

Discover this under-the-radar AI stock now, ahead of the crowd.

SpringWorks Therapeutics Price Quote

$28.57
-1.23 (-4.11%)
(Updated: October 23, 2024 at 2:00 PM ET)

SpringWorks Therapeutics Key Stats

Sell
29
SpringWorks Therapeutics (SWTX) is a Sell
Day range:
$29.78 - $30.45
52-week range:
$18.00 - $53.92
Dividend yield:
0%
P/E ratio:
0.00
P/S ratio:
0.00
P/B ratio:
3.97%
Volume:
505.8K
Avg. volume:
992.2K
1-year change:
35.56%
Market cap:
$2.2B
Revenue:
$5.4M
EPS:
$-4.44

How Much Does SpringWorks Therapeutics Make?

Data Unavailable

Is SpringWorks Therapeutics Growing As A Company?

Data Unavailable

SpringWorks Therapeutics Stock Price Performance

What Is SpringWorks Therapeutics 52-Week High & Low?

SpringWorks Therapeutics Price To Free Cash Flow

Data Unavailable

Is It Risky To Buy SpringWorks Therapeutics?

Is SpringWorks Therapeutics Cash Flow Positive?

  • What Is SWTX Cash Flow From Operations?
    Cash flow from operations (TTM) is -$233.9M
  • What Is SpringWorks Therapeutics’s Cash Flow From Financing?
    Cash flow from financing (TTM) is $301.6M
  • What Is SpringWorks Therapeutics’s Cash Flow From Investing?
    Cash flow from investing (TTM) is -$102.9M

SpringWorks Therapeutics Return On Invested Capital

  • Is Management Doing A Good Job?
    SWTX return on invested capital is -57.97%
  • What Is SpringWorks Therapeutics Return On Assets?
    ROA measures how assets are converting to revenues and is -50.43%
  • What Is SWTX Return On Equity?
    ROE is a measure of profitability and is -57.97%

SpringWorks Therapeutics Earnings Date & Stock Price

SpringWorks Therapeutics Competitors

SpringWorks Therapeutics Dividend Yield

SpringWorks Therapeutics Analyst Estimates

YoY Growth Past Surprise
EPS: 0% 49.3%
Revenue: 0% 72.74%

Analyst Recommendations

Buy Recommendations: 4
Hold Recommendations: 0
Sell Recommendations: 0
Price Target: 68.25
Upside from Last Price: 129.07%

Major Shareholders

  • How many SWTX shares are owned by institutional investors?
    129.1M SWTX shares are owned by institutional investors
  • How many SWTX shares are owned by insiders?
    2.9M SWTX shares are owned by insiders